» Articles » PMID: 23241431

Transcutaneous Vagus Nerve Stimulation for the Treatment of Depression: a Study Protocol for a Double Blinded Randomized Clinical Trial

Overview
Publisher Biomed Central
Date 2012 Dec 18
PMID 23241431
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Depressive disorders are the most common form of mental disorders in community and health care settings. Unfortunately, the treatment of Major Depressive Disorder (MDD) is far from satisfactory. Vagus nerve stimulation (VNS) is a relatively new and promising physical treatment for depressive disorders. One particularly appealing element of VNS is the long-term benefit in mood regulation. However, because this intervention involves surgery, perioperative risks, and potentially significant side effects, this treatment has been limited to those patients with treatment-resistant depression who have failed medication trials and exhausted established somatic treatments for major depression, due to intolerance or lack of response.This double-blinded randomized clinical trial aims to overcome these limitations by introducing a novel method of stimulating superficial branches of the vagus nerve on the ear to treat MDD. The rationale is that direct stimulation of the afferent nerve fibers on the ear area with afferent vagus nerve distribution should produce a similar effect as classic VNS in reducing depressive symptoms without the burden of surgical intervention.

Design: One hundred twenty cases (60 males) of volunteer patients with mild and moderate depression will be randomly divided into transcutaneous vagus nerve stimulation group (tVNS) and sham tVNS group. The treatment period lasts 4 months and all clinical and physiological measurements are acquired at the beginning and the end of the treatment period.

Discussion: This study has the potential to significantly extend the application of VNS treatment for MDD and other disorders (including epilepsy, bipolar disorder, and morbid obesity), resulting in direct benefit to the patients suffering from these highly prevalent disorders. In addition, the results of this double-blinded clinical trial will shed new light on our understanding of acupuncture point specificity, and development of methodologies in clinical trials of acupuncture treatment.

Trials Registration: Clinical Trials. ChiCTR-TRC-11001201 http://www.chictr.org/cn/

Citing Articles

Protocol for a nested case-control study: identifying neuroimaging biomarkers for the progression of subclinical depression and qi-stagnation constitution to major depressive disorder in adolescents.

Wang J, Zhang C, Zhang Y, Liu Y, Zhang J, Fang X Front Psychiatry. 2025; 15:1516846.

PMID: 39906680 PMC: 11790624. DOI: 10.3389/fpsyt.2024.1516846.


Transcutaneous Auricular Vagus Nerve Stimulation to Improve Emotional State.

Aranberri Ruiz A Biomedicines. 2024; 12(2).

PMID: 38398009 PMC: 10886536. DOI: 10.3390/biomedicines12020407.


Cervical Manipulation and Koren Specific Technique Emotions Protocol in the Improvement of Intensive Nocturnal Dry Cough: A Case Report.

Chang H Cureus. 2024; 16(1):e51502.

PMID: 38304660 PMC: 10831779. DOI: 10.7759/cureus.51502.


Subdiaphragmatic vagal nerve stimulation attenuates the development of hypertension and alters nucleus of the solitary tract transcriptional networks in the spontaneously hypertensive rat.

Dirr E, Jiracek L, Baekey D, Martyniuk C, Otto K, Zubcevic J Physiol Genomics. 2023; 55(12):606-617.

PMID: 37746712 PMC: 11178265. DOI: 10.1152/physiolgenomics.00016.2023.


Management of auricular transcutaneous neuromodulation and electro-acupuncture of the vagus nerve for chronic migraine: a systematic review.

Fernandez-Hernando D, Fernandez-de-Las-Penas C, Pareja-Grande J, Garcia-Esteo F, Mesa-Jimenez J Front Neurosci. 2023; 17:1151892.

PMID: 37397439 PMC: 10309039. DOI: 10.3389/fnins.2023.1151892.


References
1.
Yang A, Zhang J, Rong P, Liu H, Chen N, Zhu B . A new choice for the treatment of epilepsy: electrical auricula-vagus-stimulation. Med Hypotheses. 2011; 77(2):244-5. DOI: 10.1016/j.mehy.2011.04.021. View

2.
Jensen M, Karoly P . Motivation and expectancy factors in symptom perception: a laboratory study of the placebo effect. Psychosom Med. 1991; 53(2):144-52. DOI: 10.1097/00006842-199103000-00004. View

3.
Gao X, Zhang S, Zhu B, Zhang H . Investigation of specificity of auricular acupuncture points in regulation of autonomic function in anesthetized rats. Auton Neurosci. 2007; 138(1-2):50-6. DOI: 10.1016/j.autneu.2007.10.003. View

4.
Stefan H, Kreiselmeyer G, Kerling F, Kurzbuch K, Rauch C, Heers M . Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial. Epilepsia. 2012; 53(7):e115-8. DOI: 10.1111/j.1528-1167.2012.03492.x. View

5.
Sperling W, Reulbach U, Kornhuber J . Clinical benefits and cost effectiveness of vagus nerve stimulation in a long-term treatment of patients with major depression. Pharmacopsychiatry. 2009; 42(3):85-8. DOI: 10.1055/s-0028-1103294. View